Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Johns Hopkins researchers have used deep neural networks to draw important insights—prescriptive as well as descriptive—into adaptive immunity from massive stores of T-cell receptor sequencing data.
Noting that multiple sclerosis now affects more people between 50 and 60 than any other age group, researchers have shown how machine-learning gait analysis can help personalize therapy regimens.
Academic researchers in the U.K. have completed a systematic review of 62 representative studies on the use of AI for COVID-19 diagnostics and prognostics on X-rays and CT scans. Their findings may strike some as a setback.
Researchers have demonstrated that deep learning models can help neurologists interpret epileptic episodes during and between seizures from relatively few scalp electroencephalography (EEG) readings.
Researchers have developed an AI-based system that can direct the administering of iron and other red-blood-cell stimulators nearly as well as experienced physicians.
